22 July 2024
Marlowe plc
Holding(s) in Company
Marlowe plc ("Marlowe" or the "Group"), the leader in business-critical services, announces that it has today been notified, in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules and as a result of the repurchase and cancellation by the Company of Ordinary Shares in accordance with the terms of Marlowe's buyback programme announced on 22 May 2024, that Lord Michael Ashcroft KCMG PC, Interim Non-Executive Chairman of Marlowe, crossed a notifiable threshold in his percentage shareholding of ordinary shares of 50 pence each in the Company ("Ordinary Shares") on 19 July 2024.
Lord Ashcroft PCMG PC remains beneficially interested in an unchanged 15,310,170 Ordinary Shares, now representing 17.17 per cent. of the Group's issued ordinary share capital.
For further information:
| Marlowe plc | ||
| Lord Michael Ashcroft, Interim Non-Executive Chair | ||
| Adam Councell, Chief Financial Officer | Tel: +44 (0) 203 813 8498 | |
| Benjamin Tucker, Head of Investor Relations | | |
| | | |
| Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) | ||
| Ben Jeynes | Tel: +44 (0)20 7220 0500 | |
| George Lawson | | |
| | | |
| Investec Bank plc (Joint Broker) | ||
| Henry Reast | Tel: +44 (0)20 7597 5970 | |
| Oliver Cardigan | | |
| | | |
| FTI Consulting | | |
| Nick Hasell | Tel: +44 (0)20 3727 1340 | |
| Alex Le May | | |
About Marlowe plc
Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security, Water & Air Hygiene and Occupational Health. The Group has a national footprint and serves over 30,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.